Metwin G 0.5mg/500mg Tablet

Name: Metwin G 0.5mg/500mg Tablet
Brand: Ranmarc Labs
Price: 35 INR

Prescription Required

Marketer

Ranmarc Labs

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Metwin G 0.5mg/500mg Tablet

Diabetica G 0.5mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetica G should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, risking complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms including sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are vital to mitigate this risk. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are necessary.

Primary Ingredients of Metwin G 0.5mg/500mg Tablet

No information provided. A rephrased version cannot be created.

Uses of Metwin G 0.5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Metwin G 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.5mg/500mg Metwin G tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medicine with food.

Common Side effects of Metwin G 0.5mg/500mg Tablet:

Headache
Hypoglycemia (low blood glucose level)
Nausea
Diarrhea

How to use Metwin G 0.5mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. The Metwin G 0.5mg/500mg Tablet should be administered with food.

How Metwin G 0.5mg/500mg Tablet works:

Each Metwin G 0.5mg/500mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), two medications used to manage diabetes. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholUNSAFE

Concurrent alcohol use and Metwin G 0.5mg/500mg tablets is inadvisable.

PregnancyCONSULT YOUR DOCTOR

The use of Metwin G 0.5mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Physician consultation is advised.

Breast feedingUNSAFE

Lactation is contraindicated with Metwin G 0.5mg/500mg tablets due to potential infant toxicity.

DrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyCAUTION

Patients with kidney impairment should exercise caution when using Metwin G 0.5mg/500mg tablets, potentially requiring dosage modification. Consult a physician for guidance. Metwin G 0.5mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverCAUTION

Patients with liver impairment should use Metwin G 0.5mg/500mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metwin G 0.5mg/500mg Tablet :

Should you forget to take your Metwin G 0.5mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metwin G 0.5mg/500mg Tablet

Label	Value
Developing Habits	No.
Treatment Category	Diabetes Management

FAQs on Metwin G 0.5mg/500mg Tablet

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.

Metwin G 0.5mg/500mg Tablets can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Metwin G 0.5mg/500mg Tablets and seek immediate medical attention.

Metwin G 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is unsuitable for type 1 DM.

Metwin G 0.5mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.

Prolonged Metwin G 0.5mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.

Metwin G 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.

Combining Metwin G 0.5mg/500mg tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.

MRP 40

12% off

Inclusive of all taxes

Quantity:

of Tablet

Metwin G 0.5mg/500mg Tabl...

MRP 40

12% off

Hi there!

Connect

Social Links

Drugs